A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults

PHASE3CompletedINTERVENTIONAL

Enrollment

148

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

July 31, 2015

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG

ABT-450/r/ABT-267, ABT-333

Tablet; ABT-450 coformulated with ritonavir and ABT-267, ABT-333 tablet

DRUG

Ribavirin

Tablet

DRUG

Pegylated Interferon a-2a (PegINF)

Pre-filled syringe

DRUG

Telaprevir

Film-coated tablet